Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.


This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    Hot Stocks: Toyota Motor Corp. (NYSE: TM) Won't Be Back on Track Any Time Soon

    Don't count on Toyota Motor Corp. (NYSE ADR: TM) to regain its place as the leader in global auto sales any time soon.

    Because even though the company is ahead of schedule as it looks to bounce back from the horrible wave of disasters that engulfed Japan in the spring, it now faces another roadblock in the strengthening yen.

    Indeed, the good news for Toyota is that it now expects full production in Japan to resume by September, two months earlier than originally predicted. But the bad news for the company is that the dollar has slid from over 90 yen a year ago to about 80 yen now, making all Japanese exports increasingly expensive. The break-even point for Toyota is around 85 yen to the dollar.

    For every yen of appreciation, Toyota would need to raise the price of its autos in the United States by 1.25% to maintain the same profit, an unappealing alternative in a challenging economy.

    To continue reading, please click here ...

  • toyota motor corp. (NYSE: TM)

  • Toyota Motor Corp. (NYSE: TM) CFO Encourages Global Production Shift as Profits Tumble Toyota Motor Corp. (NYSE: TM) reported a staggering 77% decline in quarterly profits this month due to production disruption from the Japan earthquake and a strengthening yen. Many now wonder if the automaker can maintain its strong manufacturing presence in Japan without losing too much in profit.

    Chief Financial Officer Satoshi Ozawa said at a news conference yesterday (Wednesday) that he will advise Toyota President Akio Toyoda on the need to rebalance the company's domestic and overseas production. Toyota makes 45% of its vehicles in Japan.

    Toyota has "reached the limits of our ability to manufacture in Japan," said Ozawa. "We have done as much as we can do as a single company."